Literature DB >> 16009876

Neutralizing anti-IFN-beta antibodies: how much more evidence do we need to use them in practice?

Gavin Giovannoni, Andrew Goodman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009876     DOI: 10.1212/01.wnl.0000172080.54415.f1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Neutralizing antibodies against interferon-Beta.

Authors:  Per Soelberg Sorensen
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 2.  Diagnosis and treatment of multiple sclerosis.

Authors:  T J Murray
Journal:  BMJ       Date:  2006-03-04

3.  Management of neutralizing antibodies against beta-IFN in beta-IFN-treated multiple sclerosis patients.

Authors:  Andrew R Pachner; Jennifer Brady; Israel Steiner; Kavitha Narayan
Journal:  J Neurol       Date:  2008-11-22       Impact factor: 4.849

4.  Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis.

Authors:  Konstantin E Balashov; Latt Latt Aung; Adi Vaknin-Dembinsky; Suhayl Dhib-Jalbut; Howard L Weiner
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

5.  Improving compliance with interferon-beta therapy in patients with multiple sclerosis.

Authors:  Emilio Portaccio; Maria Pia Amato
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies.

Authors:  Carolina Scagnolari; Petra Duda; Francesca Bagnato; Gabriella De Vito; Alessia Alberelli; Vito Lavolpe; Enrico Girardi; Valentina Durastanti; Maria Trojano; Ludwig Kappos; Guido Antonelli
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 4.849

7.  Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures.

Authors:  Enrique Alvarez; Laura Piccio; Robert J Mikesell; Kathryn Trinkaus; Becky J Parks; Robert T Naismith; Anne H Cross
Journal:  Mult Scler J Exp Transl Clin       Date:  2015-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.